Cigna Group Files 8-K/A Amendment

TL;DR

Cigna Group filed an amendment to an 8-K, updating info on execs and board changes.

AI Summary

The Cigna Group filed an 8-K/A amendment on July 28, 2025, related to events occurring on May 30, 2025. The filing pertains to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. This amendment updates information previously reported.

Why It Matters

This filing is an amendment to a previous report, indicating updates or corrections to information regarding Cigna Group's board of directors and executive compensation. Investors should review the amendment for any changes to governance or executive pay structures.

Risk Assessment

Risk Level: low — This is an amendment to a previous filing, typically for corrections or updates, and does not represent a new material event.

Key Players & Entities

• The Cigna Group (company) — Registrant
• Delaware (jurisdiction) — State of incorporation
• 001-38769 (filing_number) — SEC File Number
• 82-4991898 (ein) — IRS Employer Identification No.
• 900 Cottage Grove Road (address) — Principal executive offices
• Bloomfield (city) — Principal executive offices
• Connecticut (state) — Principal executive offices
• 06002 (zip_code) — Principal executive offices
• 8602266000 (phone_number) — Registrant's telephone number
• May 30, 2025 (date) — Date of earliest event reported

FAQ

From the Filing

0001140361-25-027585.txt : 20250728 0001140361-25-027585.hdr.sgml : 20250728 20250728161648 ACCESSION NUMBER: 0001140361-25-027585 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20250530 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20250728 DATE AS OF CHANGE: 20250728 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cigna Group CENTRAL INDEX KEY: 0001739940 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance EIN: 824991898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38769 FILM NUMBER: 251155844 BUSINESS ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 BUSINESS PHONE: 8602266000 MAIL ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 FORMER COMPANY: FORMER CONFORMED NAME: Cigna Corp DATE OF NAME CHANGE: 20181221 FORMER COMPANY: FORMER CONFORMED NAME: Halfmoon Parent, Inc. DATE OF NAME CHANGE: 20180508 8-K/A 1 ef20052733_8ka.htm 8K/A false 0001739940 0001739940 2025-05-30 2025-05-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 30, 2025 The Cigna Group (Exact name of registrant as specified in its charter) Delaware 001-38769 82-4991898 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 900 Cottage Grove Road Bloomfield , Connecticut 06002 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: ( 860 ) 226-6000 Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $0.01 CI New York Stock Exchange , Inc Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐   Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On June 2, 2025, The Cigna Group (the “Company”) filed a Current Report on Form 8-K announcing the action by the Company’s Board of Directors (the “Board”) on May 30, 2025 to appoint Michael J. Hennigan as an independent member of the Board, effective June 2, 2025. At the time of his appointment, the Board had not determined on which committees Mr. Hennigan would serve.  This Form 8-K/A is being filed for the purpose of providing this information.   On July 22, 2025, the Board appointed Mr. Hennigan to the Audit a